Emodin ve Anti-Tümoral Etkisi

Hernández ML, Osorio S, Florez K, et al. Abbreviated magnetic resonance imaging in breast cancer: a systematic review of literature. European Journal of Radiology Open; 2021;8:100307. doi:10.1016/j.ejro.2020.100307

Dhanikula AB, Panchagnula R. Localized paclitaxel delivery. International Journal of Pharmaceutics; 1999;183(2): 85-100. doi:10.1016/s0378-5173(99)00087-3

Schwartsmann G, Ratain MJ, Cragg GM, et al. Anticancer drug discovery and development throughout the world. Journal of Clinical Oncology; 2002;20(18): 47-59. PMID:12235225

Li-Weber M. Targeting apoptosis pathways in cancer by Chinese medicine. Cancer Letters; 2013;332(2): 304-312. doi:10.1016/j.canlet.2010.07.015

Wang JB, Zhao HP, Zhao YL, et al. Hepatotoxicity or hepatoprotection? Pattern recognition for the paradoxical effect of the Chinese herb Rheum palmatum L. in treating rat liver injury. PLoS One; 2011;6(9): e24498. doi:10.1371/journal.pone.0024498

Wang M, Zhao R, Wang W, et al. Lipid regulation effects of Polygoni Multiflori Radix, its processed products and its major substances on steatosis human liver cell line L02. Journal of Ethnopharmacology; 2012;139(1): 287-293. doi:10.1016/j.jep.2011.11.022

Shrimali D, Shanmugam MK, Kumar AP, et al. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer. Cancer Letters; 2013; 341(2): 139-149. doi:10.1016/j.canlet.2013.08.023

Lin ML, Lu YC, Chung JG, et al. Aloe-emodin induces apoptosis of human nasopharyngeal carcinoma cells via caspase-8-mediated activation of the mitochondrial death pathway. Cancer Letters; 2010; 291(1): 46-58. doi:10.1016/j.canlet.2009.09.016

Matsuda Y, Yokohira M, Suzuki S, et al. One-year chronic toxicity study of Aloe arborescens Miller var. natalensis Berger in Wistar Hannover rats. A pilot study. Food and Chemical Toxicology; 2008;46(2): 733-739. doi:10.1016/j.fct.2007.09.107

Xing JY, Song GP, Deng JP, et al. Antitumor effects and mechanism of novel emodin rhamnoside derivatives against human cancer cells in vitro. PLoS One; 2015; 10(12): e0144781. doi:10.1371/journal.pone.0144781

Chun-Guang W, Jun-Qing Y, Bei-Zhong L, et al. Anti-tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo. European Journal of Pharmacology; 2010;627(1-3): 33-41. doi:10.1016/j.ejphar.2009.10.035

Wei WT, Lin SZ, Liu DL, et al. The distinct mechanisms of the antitumor activity of emodin in different types of cancer. Oncology; 2013;30(6): 2555-2562. doi:10.3892/or.2013.2741

Yi J, Yang J, He R, et al. Emodin enhances arsenic trioxide-induced apoptosis via generation of reactive oxygen species and inhibition of survival signaling. Cancer Research; 2004;64(1): 108-116. doi:10.1158/0008-5472.can-2820-2

Yu CX, Zhang XQ, Kang LD, et al. Emodin induces apoptosis in human prostate cancer cell LNCaP. Asian Journal of Andrology; 2008;10(4): 625-634. doi:10.1111/j.1745-7262.2008.00397.x

Huang Z, Chen G, Shi P. Effects of emodin on the gene expression profiling of human breast carcinoma cells. Cancer Detection and Prevention; 2009;32(4): 286-291. doi:10.1016/j.cdp.2008.12.003

Su YJ, Tsai MS, Kuo YH, et al. Role of Rad51 down-regulation and extracellular signal-regulated kinases 1 and 2 inactivation in emodin and mitomycin C-induced synergistic cytotoxicity in human non–small-cell lung cancer cells. Molecular Pharmacology; 2010;77(4): 633-643. doi:10.1124/mol.109.061887

Ko JC, Su YJ, Lin ST, et al. Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2. Lung Cancer; 2010;69(2): 155-164. doi:10.1016/j.lungcan.2009.10.013

Vlahopoulos S, Zoumpourlis VC. JNK: a key modulator of intracellular signaling. Biochemistry (Moscow); 2004;69: 844-854. doi:10.1023/b:biry.0000040215.02460.45

Ma J, Yang J, Wang C, et al. Emodin augments cisplatin cytotoxicity in platinum-resistant ovarian cancer cells via ROS-dependent MRP1 downregulation. BioMed Research International; 2014. doi:10.1155/2014/107671

Li XX, Dong Y, Wang W, et al. Emodin as an effective agent in targeting cancer stem-like side population cells of gallbladder carcinoma. Stem Cells and Development; 2013;22(4): 554-566. doi:10.1089/scd.2011.0709

Yu JQ, Bao W, Lei JC. Emodin regulates apoptotic pathway in human liver cancer cells. Phytotherapy Research; 2013;27(2): 251-257. doi:10.1002/ptr.4703

Wang H, Li X, Chen T, et al. Mechanisms of verapamil-enhanced chemosensitivity of gallbladder cancer cells to platinum drugs: glutathione reduction and MRP1 downregulation. Oncology Reports; 2013;29(2): 676-684. doi:10.3892/or.2012.2156

Huang L, Wang XB, Yu QM, et al. Synergistic cancer growth-inhibitory effect of emodin and low-dose cisplatin on gastric cancer cells in vitro. Tropical Journal of Pharmaceutical Research; 2015;14(8): 1427-1434. doi:10.4314/tjpr.v14i8.15

Chen P, Liu Y, Sun Y, et al. AZT and emodin exhibit synergistic growth-inhibitory effects on K562/ADM cells by inducing S phase cell cycle arrest and suppressing MDR1 mRNA/p-gp protein expression. Pharmaceutical Biology; 2013;51(12): 1586-1591. doi:10.3109/13880209.2013.803257

Li J, Liu P, Mao H, et al. Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro. Oncology Reports; 2009;21(6): 1605-1610. PMID:19424643

Kim MJ, Oh DY, Lee SH, et al. Gemcitabine-based versusfluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: A retrospective study. BMC Cancer; 2008;8(1): 1-9. doi:10.1186/1471-2407-8-374

Wang W, Sun Y, Li X, et al. Emodin potentiates the anticancer effect of cisplatin on gallbladder cancer cells through the generation of reactive oxygen species and the inhibition of survivin expression. Oncology; 2011;26(5): 1143-1148. doi:10.3892/or.2011.1390

Li WY, Ng YF, Zhang H, et al. Emodin elicits cytotoxicity in human lung adenocarcinoma A549 cells through inducing apoptosis. Inflammopharmacology; 2014;22: 127-134. doi:10.1007/s10787-013-0186-4

Dong X, Fu J, Yin X, et al. Emodin: a review of its pharmacology, toxicity and pharmacokinetics. Phytotherapy Research; 2016;30(8): 1207-1218. doi:10.1002/ptr.5631

Chen YY, Chiang SY, Lin JG, et al. Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9. International Journal of Oncology; 2010;36(5): 1113-1120. doi:10.3892/ijo_00000593.

Ma YS, Weng SW, Lin MW, et al. Antitumor effects of emodin on LS1034 human colon cancer cells in vitro and in vivo: Roles of apoptotic cell death and LS1034 tumor xenografts model. Food and Chemical Toxicology; 2012;50(5): 1271-1278. doi:10.1016/j.fct.2012.01.033.

Saha S, Bardelli A, Buckhaults P, et al. A phosphatase associated with metastasis of colorectal cancer. Science; 2001;294(5545): 1343-1346. doi:10.1126/science.1065817.

Chen YY, Chiang SY, Lin JG, et al. Emodin, aloe-emodin and rhein induced DNA damage and inhibited DNA repair gene expression in SCC-4 human tongue cancer cells. Anticancer Research; 2010;30(3): 945-951. PMID:20393018

Hsu CM, Hsu YA, Tsai Y, et al. Emodin inhibits the growth of hepatoma cells: finding the common anti-cancer pathway using Huh7, Hep3B, and HepG2 cells. Biochemical and Biophysical Research Communications; 2010;392(4): 473-478. doi:10.1016/j.bbrc.2009.10.153

Mondal S, Adhikari N, Banerjee S, et al. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview. European Journal of Medicinal Chemistry; 2020;194: 112260. doi:10.1016/j.ejmech.2020.112260

Jayasuriya H, Koonchanok NM, Geahlen RL, et al. Emodin, a protein tyrosine kinase inhibitor from Polygonum cuspidatum. Journal of Natural Products; 1992;55(5): 696-698. doi:10.1021/np50083a026

Zhang L, Chang CJ, Bacus SS, et al. Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin. Cancer Research; 1995;55(17): 3890-3896. PMID:7543819

Zhang L, Lau YK, Xia W, et al. Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel. Clinical Cancer Research; 1999;5(2): 343-353. PMID:10037184

Huang PH, Huang CY, Chen MC, et al. Emodin and aloe-emodin suppress breast cancer cell proliferation through ERα inhibition. Evidence-Based Complementary and Alternative Medicine; 2013. doi:10.1155/2013/376123